Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Rifaximin prevents ethanol-induced liver injury in obese KK-Ay mice through modulation of small intestinal microbiota signature.

Kitagawa R, Kon K, Uchiyama A, Arai K, Yamashina S, Kuwahara-Arai K, Kirikae T, Ueno T, Ikejima K.

Am J Physiol Gastrointest Liver Physiol. 2019 Sep 11. doi: 10.1152/ajpgi.00372.2018. [Epub ahead of print]

PMID:
31509430
2.

Evaluation of a new selective agar medium for detection of carbapenem-resistant Enterobacteriaceae.

Kuwahara-Arai K, Morito A, Yanagisawa I, Hishinuma T, Mya S, Zan KN, Tohya M, Tada T, Tin HH, Sekiguchi JI, Watanabe S, Kirikae T.

Diagn Microbiol Infect Dis. 2019 Aug 7:114882. doi: 10.1016/j.diagmicrobio.2019.114882. [Epub ahead of print]

PMID:
31495528
3.

Enriched bovine IgG fraction prevents infections with Enterohaemorrhagic Escherichia coli O157:H7, Salmonella enterica serovar Enteritidis, and Mycobacterium avium.

Funatogawa K, Tada T, Kuwahara-Arai K, Kirikae T, Takahashi M.

Food Sci Nutr. 2019 Jul 17;7(8):2726-2730. doi: 10.1002/fsn3.1134. eCollection 2019 Aug.

4.

Characterization of novel anti-IL-26 neutralizing monoclonal antibodies for the treatment of inflammatory diseases including psoriasis.

Hatano R, Itoh T, Otsuka H, Okamoto S, Komiya E, Iwata S, Aune TM, Dang NH, Kuwahara-Arai K, Ohnuma K, Morimoto C.

MAbs. 2019 Aug 18:1-15. doi: 10.1080/19420862.2019.1654305. [Epub ahead of print]

PMID:
31397631
5.

Pseudomonas juntendi sp. nov., isolated from patients in Japan and Myanmar.

Tohya M, Watanabe S, Teramoto K, Shimojima M, Tada T, Kuwahara-Arai K, War MW, Mya S, Tin HH, Kirikae T.

Int J Syst Evol Microbiol. 2019 Aug 1. doi: 10.1099/ijsem.0.003623. [Epub ahead of print]

PMID:
31368883
6.

Assessment of a newly developed immunochromatographic assay for NDM-type metallo-β-lactamase producing Gram-negative pathogens in Myanmar.

Tada T, Sekiguchi JI, Watanabe S, Kuwahara-Arai K, Mizutani N, Yanagisawa I, Hishinuma T, Zan KN, Mya S, Tin HH, Kirikae T.

BMC Infect Dis. 2019 Jun 28;19(1):565. doi: 10.1186/s12879-019-4147-4.

7.

Emergence of Carbapenem-Resistant Pseudomonas asiatica Producing NDM-1 and VIM-2 Metallo-β-Lactamases in Myanmar.

Tohya M, Tada T, Watanabe S, Kuwahara-Arai K, Zin KN, Zaw NN, Aung MY, Mya S, Zan KN, Kirikae T, Tin HH.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00475-19. doi: 10.1128/AAC.00475-19. Print 2019 Aug.

PMID:
31138570
8.

Pseudomonas asiatica sp. nov., isolated from hospitalized patients in Japan and Myanmar.

Tohya M, Watanabe S, Teramoto K, Uechi K, Tada T, Kuwahara-Arai K, Kinjo T, Maeda S, Nakasone I, Zaw NN, Mya S, Zan KN, Tin HH, Fujita J, Kirikae T.

Int J Syst Evol Microbiol. 2019 May;69(5):1361-1368. doi: 10.1099/ijsem.0.003316. Epub 2019 Feb 27.

PMID:
30810522
9.

Molecular Characterization of Multidrug-Resistant Pseudomonas aeruginosa Isolates in Hospitals in Myanmar.

Tada T, Hishinuma T, Watanabe S, Uchida H, Tohya M, Kuwahara-Arai K, Mya S, Zan KN, Kirikae T, Tin HH.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02397-18. doi: 10.1128/AAC.02397-18. Print 2019 May.

PMID:
30803967
10.

An improved carbapenem inactivation method, CIMTrisII, for carbapenemase production by Gram-negative pathogens.

Uechi K, Tada T, Kuwahara-Arai K, Sekiguchi JI, Yanagisawa I, Tome T, Nakasone I, Maeda S, Mya S, Zan KN, Tin HH, Kirikae T, Fujita J.

J Med Microbiol. 2019 Feb;68(2):124-131. doi: 10.1099/jmm.0.000888. Epub 2018 Dec 10.

PMID:
30526741
11.

Faecal freezing preservation period influences colonization ability for faecal microbiota transplantation.

Takahashi M, Ishikawa D, Sasaki T, Lu YJ, Kuwahara-Arai K, Kamei M, Shibuya T, Osada T, Hiramatsu K, Nagahara A.

J Appl Microbiol. 2019 Mar;126(3):973-984. doi: 10.1111/jam.14167. Epub 2019 Jan 7.

PMID:
30489686
12.

Spread of GES-5 carbapenemase-producing Pseudomonas aeruginosa clinical isolates in Japan due to clonal expansion of ST235.

Hishinuma T, Tada T, Kuwahara-Arai K, Yamamoto N, Shimojima M, Kirikae T.

PLoS One. 2018 Nov 19;13(11):e0207134. doi: 10.1371/journal.pone.0207134. eCollection 2018.

13.

The Microbial Composition of Bacteroidetes Species in Ulcerative Colitis Is Effectively Improved by Combination Therapy With Fecal Microbiota Transplantation and Antibiotics.

Ishikawa D, Sasaki T, Takahashi M, Kuwahara-Arai K, Haga K, Ito S, Okahara K, Nakajima A, Shibuya T, Osada T, Hiramatsu K, Watanabe S, Nagahara A.

Inflamm Bowel Dis. 2018 Nov 29;24(12):2590-2598. doi: 10.1093/ibd/izy266.

PMID:
30124831
14.

Development of a New Application for Comprehensive Viability Analysis Based on Microbiome Analysis by Next-Generation Sequencing: Insights into Staphylococcal Carriage in Human Nasal Cavities.

Lu YJ, Sasaki T, Kuwahara-Arai K, Uehara Y, Hiramatsu K.

Appl Environ Microbiol. 2018 May 17;84(11). pii: e00517-18. doi: 10.1128/AEM.00517-18. Print 2018 Jun 1.

15.

A Modified Carbapenem Inactivation Method, CIMTris, for Carbapenemase Production in Acinetobacter and Pseudomonas Species.

Uechi K, Tada T, Shimada K, Kuwahara-Arai K, Arakaki M, Tome T, Nakasone I, Maeda S, Kirikae T, Fujita J.

J Clin Microbiol. 2017 Dec;55(12):3405-3410. doi: 10.1128/JCM.00893-17. Epub 2017 Sep 27.

16.

Antimicrobial cathelicidin peptide LL‑37 induces NET formation and suppresses the inflammatory response in a mouse septic model.

Hosoda H, Nakamura K, Hu Z, Tamura H, Reich J, Kuwahara-Arai K, Iba T, Tabe Y, Nagaoaka I.

Mol Med Rep. 2017 Oct;16(4):5618-5626. doi: 10.3892/mmr.2017.7267. Epub 2017 Aug 17.

PMID:
28849130
17.

Evaluation of the effect of recombinant thrombomodulin on a lipopolysaccharide-induced murine sepsis model.

Takehara K, Murakami T, Kuwahara-Arai K, Iba T, Nagaoka I, Sakamoto K.

Exp Ther Med. 2017 Jun;13(6):2969-2974. doi: 10.3892/etm.2017.4308. Epub 2017 Apr 5.

18.

Spleen-derived lipocalin-2 in the portal vein regulates Kupffer cells activation and attenuates the development of liver fibrosis in mice.

Aoyama T, Kuwahara-Arai K, Uchiyama A, Kon K, Okubo H, Yamashina S, Ikejima K, Kokubu S, Miyazaki A, Watanabe S.

Lab Invest. 2017 Aug;97(8):890-902. doi: 10.1038/labinvest.2017.44. Epub 2017 May 15.

19.

Neutrophil extracellular traps induce IL-1β production by macrophages in combination with lipopolysaccharide.

Hu Z, Murakami T, Tamura H, Reich J, Kuwahara-Arai K, Iba T, Tabe Y, Nagaoka I.

Int J Mol Med. 2017 Mar;39(3):549-558. doi: 10.3892/ijmm.2017.2870. Epub 2017 Jan 27.

20.

Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis.

Ishikawa D, Sasaki T, Osada T, Kuwahara-Arai K, Haga K, Shibuya T, Hiramatsu K, Watanabe S.

Inflamm Bowel Dis. 2017 Jan;23(1):116-125. doi: 10.1097/MIB.0000000000000975.

PMID:
27893543
21.

Antimicrobial cathelicidin peptide LL-37 inhibits the pyroptosis of macrophages and improves the survival of polybacterial septic mice.

Hu Z, Murakami T, Suzuki K, Tamura H, Reich J, Kuwahara-Arai K, Iba T, Nagaoka I.

Int Immunol. 2016 May;28(5):245-53. doi: 10.1093/intimm/dxv113. Epub 2016 Jan 7.

22.

Human Host Defense Cathelicidin Peptide LL-37 Enhances the Lipopolysaccharide Uptake by Liver Sinusoidal Endothelial Cells without Cell Activation.

Suzuki K, Murakami T, Hu Z, Tamura H, Kuwahara-Arai K, Iba T, Nagaoka I.

J Immunol. 2016 Feb 1;196(3):1338-47. doi: 10.4049/jimmunol.1403203. Epub 2016 Jan 4.

23.

Complete Genome Sequence of Methicillin-Resistant Staphylococcus schleiferi Strain TSCC54 of Canine Origin.

Sasaki T, Tsubakishita S, Kuwahara-Arai K, Matsuo M, Lu YJ, Tanaka Y, Hiramatsu K.

Genome Announc. 2015 Oct 29;3(5). pii: e01268-15. doi: 10.1128/genomeA.01268-15.

24.

"Slow VISA," a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3.

Saito M, Katayama Y, Hishinuma T, Iwamoto A, Aiba Y, Kuwahara-Arai K, Cui L, Matsuo M, Aritaka N, Hiramatsu K.

Antimicrob Agents Chemother. 2014 Sep;58(9):5024-35. doi: 10.1128/AAC.02470-13. Epub 2014 May 19.

25.

Antimicrobial cathelicidin peptide LL-37 inhibits the LPS/ATP-induced pyroptosis of macrophages by dual mechanism.

Hu Z, Murakami T, Suzuki K, Tamura H, Kuwahara-Arai K, Iba T, Nagaoka I.

PLoS One. 2014 Jan 16;9(1):e85765. doi: 10.1371/journal.pone.0085765. eCollection 2014.

26.

Genomic Basis for Methicillin Resistance in Staphylococcus aureus.

Hiramatsu K, Ito T, Tsubakishita S, Sasaki T, Takeuchi F, Morimoto Y, Katayama Y, Matsuo M, Kuwahara-Arai K, Hishinuma T, Baba T.

Infect Chemother. 2013 Jun;45(2):117-36. doi: 10.3947/ic.2013.45.2.117. Epub 2013 Jun 26. Review.

27.

Staphylococcal Cassette Chromosome mec (SCCmec) analysis of MRSA.

Ito T, Kuwahara-Arai K, Katayama Y, Uehara Y, Han X, Kondo Y, Hiramatsu K.

Methods Mol Biol. 2014;1085:131-48. doi: 10.1007/978-1-62703-664-1_8.

PMID:
24085694
28.

Investigation of nasal meticillin-resistant Staphylococcus aureus carriage in a haemodialysis clinic in Japan.

Uehara Y, Kuwahara-Arai K, Hori S, Kikuchi K, Yanai M, Hiramatsu K.

J Hosp Infect. 2013 May;84(1):81-4. doi: 10.1016/j.jhin.2013.01.004. Epub 2013 Feb 16.

PMID:
23419596
29.

Rapid and accurate identification of human-associated staphylococci by use of multiplex PCR.

Hirotaki S, Sasaki T, Kuwahara-Arai K, Hiramatsu K.

J Clin Microbiol. 2011 Oct;49(10):3627-31. doi: 10.1128/JCM.00488-11. Epub 2011 Aug 10.

30.

Human anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced apoptosis of endothelial cells.

Suzuki K, Murakami T, Kuwahara-Arai K, Tamura H, Hiramatsu K, Nagaoka I.

Int Immunol. 2011 Mar;23(3):185-93. doi: 10.1093/intimm/dxq471.

PMID:
21393634
31.

Transcription and translation products of the cytolysin gene psm-mec on the mobile genetic element SCCmec regulate Staphylococcus aureus virulence.

Kaito C, Saito Y, Nagano G, Ikuo M, Omae Y, Hanada Y, Han X, Kuwahara-Arai K, Hishinuma T, Baba T, Ito T, Hiramatsu K, Sekimizu K.

PLoS Pathog. 2011 Feb 3;7(2):e1001267. doi: 10.1371/journal.ppat.1001267.

32.

Origin and molecular evolution of the determinant of methicillin resistance in staphylococci.

Tsubakishita S, Kuwahara-Arai K, Sasaki T, Hiramatsu K.

Antimicrob Agents Chemother. 2010 Oct;54(10):4352-9. doi: 10.1128/AAC.00356-10. Epub 2010 Aug 2. Erratum in: Antimicrob Agents Chemother. 2011 Feb;55(2):946.

33.

Staphylococcal cassette chromosome mec-like element in Macrococcus caseolyticus.

Tsubakishita S, Kuwahara-Arai K, Baba T, Hiramatsu K.

Antimicrob Agents Chemother. 2010 Apr;54(4):1469-75. doi: 10.1128/AAC.00575-09. Epub 2010 Jan 19.

34.

Antimicrobial cathelicidin polypeptide CAP11 suppresses the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice.

Murakami T, Obata T, Kuwahara-Arai K, Tamura H, Hiramatsu K, Nagaoka I.

Int Immunol. 2009 Aug;21(8):905-12. doi: 10.1093/intimm/dxp057. Epub 2009 Jun 25.

PMID:
19556302
35.

Augmentation of the antimicrobial activities of guinea pig cathelicidin CAP11-derived peptides by amino acid substitutions.

Okuda D, Yomogida S, Kuwahara-Arai K, Hitamatsu K, Tamura H, Nagaoka I.

Int J Mol Med. 2009 Apr;23(4):501-8.

PMID:
19288026
36.

Complete genome sequence of Macrococcus caseolyticus strain JCSCS5402, [corrected] reflecting the ancestral genome of the human-pathogenic staphylococci.

Baba T, Kuwahara-Arai K, Uchiyama I, Takeuchi F, Ito T, Hiramatsu K.

J Bacteriol. 2009 Feb;191(4):1180-90. doi: 10.1128/JB.01058-08. Epub 2008 Dec 12. Erratum in: J Bacteriol. 2009 May;191(10):3429.

37.

Extreme genetic diversity of methicillin-resistant Staphylococcus epidermidis strains disseminated among healthy Japanese children.

Jamaluddin TZ, Kuwahara-Arai K, Hisata K, Terasawa M, Cui L, Baba T, Sotozono C, Kinoshita S, Ito T, Hiramatsu K.

J Clin Microbiol. 2008 Nov;46(11):3778-83. doi: 10.1128/JCM.02262-07. Epub 2008 Oct 1.

38.

Antibacterial cathelicidin peptide CAP11 suppresses the anandamide production from lipopolysaccharide-stimulated mononuclear phagocytes.

Murakami T, Yomogida S, Someya A, Kuwahara-Arai K, Tamura H, Nagaoka I.

FEBS Lett. 2007 Jan 9;581(1):140-4. Epub 2006 Dec 14.

39.

Dissemination of methicillin-resistant staphylococci among healthy Japanese children.

Hisata K, Kuwahara-Arai K, Yamanoto M, Ito T, Nakatomi Y, Cui L, Baba T, Terasawa M, Sotozono C, Kinoshita S, Yamashiro Y, Hiramatsu K.

J Clin Microbiol. 2005 Jul;43(7):3364-72.

40.

Augmentation of the bactericidal activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by amino acid substitutions.

Nagaoka I, Kuwahara-Arai K, Tamura H, Hiramatsu K, Hirata M.

Inflamm Res. 2005 Feb;54(2):66-73.

PMID:
15750713
41.

Has vancomycin-resistant Staphylococcus aureus started going it alone?

Hiramatsu K, Cui L, Kuwahara-Arai K.

Lancet. 2004 Aug 14-20;364(9434):565-6. No abstract available.

PMID:
15313343
42.

Physiological and molecular analysis of a mecA-negative Staphylococcus aureus clinical strain that expresses heterogeneous methicillin resistance.

Yoshida R, Kuwahara-Arai K, Baba T, Cui L, Richardson JF, Hiramatsu K.

J Antimicrob Chemother. 2003 Feb;51(2):247-55.

PMID:
12562688
43.

Eagle-type methicillin resistance: new phenotype of high methicillin resistance under mec regulator gene control.

Kondo N, Kuwahara-Arai K, Kuroda-Murakami H, Tateda-Suzuki E, Hiramatsu K.

Antimicrob Agents Chemother. 2001 Mar;45(3):815-24.

44.

Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50.

Cui L, Murakami H, Kuwahara-Arai K, Hanaki H, Hiramatsu K.

Antimicrob Agents Chemother. 2000 Sep;44(9):2276-85.

45.
46.

Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50.

Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, Hiramatsu K.

J Antimicrob Chemother. 1998 Aug;42(2):199-209.

PMID:
9738837
47.

[Mechanism of vancomycin resistance in MRSA strain Mu50].

Hanaki H, Labischinski H, Sasaki K, Kuwahara-Arai K, Inaba Y, Hiramatsu K.

Jpn J Antibiot. 1998 Mar;51(3):237-47. Japanese.

PMID:
9597552
48.
49.
50.

Distribution of mec regulator genes in methicillin-resistant Staphylococcus clinical strains.

Suzuki E, Kuwahara-Arai K, Richardson JF, Hiramatsu K.

Antimicrob Agents Chemother. 1993 Jun;37(6):1219-26.

Supplemental Content

Loading ...
Support Center